Home / Health / Tiny Protein Fights Fatty Liver Disease
Tiny Protein Fights Fatty Liver Disease
2 Jun
Summary
- TCF19 protein acts as a traffic controller for fat in liver cells.
- It converts harmful fat into safer triglycerides for storage.
- Research offers new avenues for targeted non-alcoholic fatty liver disease interventions.
A groundbreaking discovery by scientists at Kolkata's Saha Institute of Nuclear Physics has identified a protein, TCF19, within liver cells that manages fat conversion. This protein acts as a crucial regulator, transforming harmful fats into a more stable form, triglycerides, which can be stored without causing damage.
This mechanism effectively slows the advancement of liver disease, particularly non-alcoholic fatty liver disease (NAFLD), a condition affecting one in three adults and linked to obesity and diabetes. The research team, led by Professor Chandrima Das, investigated how the liver adapts to stress from modern lifestyles.
The study, which involved organoid models, animal experiments, and clinical tests on 70 people, highlights TCF19's role as a gatekeeper against liver fibrosis. This finding suggests that focusing on metabolic regulation, rather than just fat reduction, could lead to more effective treatments for NAFLD.
As NAFLD rates rise, especially among urban populations, this work provides critical insights into liver disease progression and opens new pathways for developing nuanced interventions to manage this pressing health concern.
